For the Inventor, By the Inventor

Enter assignee name

Philadelphia, PA, United States of America

Numoda Technologies, Inc.

USPTO Granted Patents = 13

% Expired Patents = 7.7

Trademarks = 1

Forward Citations = 42

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Ieda A Mancini (5 out of 5 patents)

Fernando F Alves (5 out of 5 patents)

Ann S Vurimindi (5 out of 5 patents)

4. John W Houriet, Jr (4 out of 11 patents)

5. Christopher T Mather (3 out of 3 patents)

6. Allan D Horwitz (2 out of 2 patents)

7. Jianbo Peng (2 out of 2 patents)

8. Ann S Boris (2 out of 4 patents)

9. Daniel Rohtbart (2 out of 3 patents)

10. Jeffrey Murphy (2 out of 3 patents)

11. Ambalavanan Subbiah (2 out of 2 patents)

12. Mario A Paes (2 out of 2 patents)

13. Mirela Meka (2 out of 2 patents)

14. David L Maslow (1 out of 1 patent)

15. Keith E Argenbright (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 9892236 - Automated method of generating reconciliation reports regarding mismatches of clinical data received from multiple sources during a clinical trial (2018-02-13),

2. 9672580 - Automated identification of task items that must be completed before a clinical trial database can be locked (2017-06-06),

3. 8543603 - Visualization of data relationships between components of a project (2013-09-24),

4. 8504384 - Method and article of manufacture for performing clinical trial budget analysis (2013-08-06),

5. 8396720 - Patient diagnosis using triage protocols that have customized messages at exit points (2013-03-12),

6. 8266161 - Virtual data room for displaying clinical trial status reports based on real-time clinical trial data, with information control administration module that specifies which reports are available for display (2012-09-11),

7. 8000983 - Method and apparatus for accounting and contracting for clinical trial studies (2011-08-16),

8. 7921125 - Virtual data room with access to clinical trial status reports based on real-time clinical trial data (2011-04-05),

9. 7788114 - Method and article of manufacture for performing clinical trial budget analysis (2010-08-31),

10. 7676383 - Method and article of manufacture for performing clinical trial budget analysis (2010-03-09),

11. 7657446 - Automated identification of tasks that must be completed before a clinical trial database can be locked (2010-02-02),

12. 7636668 - Method and apparatus for accounting and contracting for clinical trial studies (2009-12-22),

13. 7496610 - Computer system for portable digital data capture and data distribution (2009-02-24),

Company Overview

Numoda Technologies, Inc. is a Philadelphia-based company specializing in the development of innovative solutions for the life sciences sector. The organization focuses on providing advanced technology and services that enhance drug development processes, particularly in the areas of clinical trial management and data analytics. By leveraging cutting-edge methodologies, Numoda aims to improve the efficiency and effectiveness of research, ultimately contributing to better healthcare outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

13 Patents

#77 in Philadelphia, PA

#852 in Pennsylvania

#23,815 in US

#44,988 in the World

Philadelphia, PA, United States of America

Numoda Technologies, Inc.

Forward Citations = 42

17 inventors:

Ieda A Mancini (5 out of 5 patents)

Fernando F Alves (5 out of 5 patents)

Ann S Vurimindi (5 out of 5 patents)

4. John W Houriet, Jr (4 out of 11 patents)

5. Christopher T Mather (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Numoda Technologies, Inc.. Retrieved from https://idiyas.com/company/numoda-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…